Open-label extension study of the efficacy and safety of rufinamide adjunctive therapy in patients with Lennox-Gastaut syndrome

被引：0
|
作者：
Glauser, T
Kluger, G
Sachdeo, R
Krauss, G
Perdomo, C
Arroyo, S
机构：
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] BHZ, Vogtareuth, Germany
[3] St Peters Univ Hosp, New Brunswick, NJ USA
[4] Johns Hopkins Med Ctr, Baltimore, MD USA
[5] Eisai Med Res, Ridgefield Pk, NJ USA
来源：
EPILEPSIA | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [1] Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study
    Kluger, G.
    Glauser, T.
    Krauss, G.
    Seeruthun, R.
    Perdomo, C.
    Arroyo, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 122 (03): : 202 - 208
  • [2] ADJUNCTIVE THERAPY OF RUFINAMIDE IN LENNOX-GASTAUT SYNDROME
    Kim, S. H.
    Eun, S. H.
    Kang, H. C.
    Lee, J. S.
    Kim, H. D.
    EPILEPSIA, 2011, 52 : 209 - 209
  • [3] Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study
    Thiele, Elizabeth
    Marsh, Eric
    Mazurkiewicz-Beldzinska, Maria
    Halford, Jonathan J.
    Gunning, Boudewijn
    Devinsky, Orrin
    Checketts, Daniel
    Roberts, Claire
    EPILEPSIA, 2019, 60 (03) : 419 - 428
  • [4] Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial
    Ohtsuka, Yoko
    Yoshinaga, Harumi
    Shirasaka, Yukiyoshi
    Takayama, Rumiko
    Takano, Hiroki
    Iyoda, Kuniaki
    EPILEPSY RESEARCH, 2016, 121 : 1 - 7
  • [5] AN OPEN-LABEL MULTICENTER STUDY OF TOPIRAMATE IN PATIENTS WITH THE LENNOX-GASTAUT SYNDROME
    FRENCH, JA
    BOURGEOIS, BFD
    DREIFUS, FE
    GLAUSER, TA
    RITTER, RJ
    REIFE, RA
    SHEILDS, WD
    CONOVER, D
    NEUROLOGY, 1995, 45 (04) : A250 - A250
  • [6] Rufinamide in patients with Lennox-Gastaut syndrome
    Clark, Peggy O.
    Gibson, Patricia A.
    NURSING-RESEARCH AND REVIEWS, 2016, 6 : 51 - 59
  • [7] Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study
    Ng, Yu-Tze
    Conry, Joan
    Paolicchi, Juliann
    Kernitsky, Lydia
    Mitchell, Wendy
    Drummond, Rebecca
    Isojarvi, Jouko
    Lee, Deborah
    Owen, Randall
    EPILEPSY & BEHAVIOR, 2012, 25 (04) : 687 - 694
  • [8] USE OF ADJUNCTIVE RUFINAMIDE FOR PATIENTS WITH LENNOX-GASTAUT SYNDROME IN CLINICAL PRACTICE
    Auvin, S.
    Papon, A.
    Bellavoine, V
    Storme, T.
    Merdariu, D.
    Ilea, A.
    Bourdon, O.
    Corny, J.
    EPILEPSIA, 2014, 55 : 111 - 111
  • [9] Pharmacokinetic and pharmacodynamic parameters of adjunctive rufinamide in patients with Lennox-Gastaut syndrome
    Critchley, D
    Fuseau, E
    Perdomo, C
    Arroyo, S
    EPILEPSIA, 2005, 46 : 209 - 209
  • [10] Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
    Balagura, Ganna
    Riva, Antonella
    Marchese, Francesca
    Verrotti, Alberto
    Striano, Pasquale
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 369 - 379
12345